Update in relation to Placing

RNS Number : 1848Z
Proxama PLC
09 December 2014
 

THIS ANNOUNCEMENT IS RESTRICTED AND IT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, THE REPUBLIC OF IRELAND OR AUSTRALIA OR ANY OTHER STATE OR JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Proxama Plc

("Proxama" or the "Group" or the "Company")

Update in relation to Placing

On 4 November 2014, Proxama, the global platform provider of mobile proximity marketing, mobile wallet and payment solutions, announced the terms of a conditional placing of up to 160,000,000 new ordinary shares of 1 pence each in the Company at a price of 2.5 pence per share to raise approximately £4.0 million before expenses (the "Placing").

On 28 November 2014, Proxama announced the completion of the first stage of the Placing (the "Tranche One Placing"), pursuant to which a total of 130,925,040 new Ordinary Shares were subscribed by institutional and other investors (including certain directors of the Company), raising £3,273,126 for the Company before expenses.

Following completion of the acquisition of Aconite Technologies Limited, announced by the Company on 5 December 2014, Proxama is please to announce that all conditions to completion of the second and third tranches to the Placing (other than that relating Admission) have now been satisfied or waived. Accordingly, the Company has conditionally allotted a total of 29,074,960 new Ordinary Shares to placees subscribing for new Ordinary Shares pursuant to the second and third tranches of the Placing. Application has been made to the London Stock Exchange for those new Ordinary Shares to be admitted to trading on AIM and it is expected that Admission will become effective on 10 December 2014.

 

Following Admission, the Company will have 1,018,466,932 Ordinary Shares in issue with each Ordinary Share carrying the right to one vote. There are no Ordinary Shares currently held in treasury. The total number of voting rights in the Company therefore will be 1,018,466,932 and this figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Rules and Transparency Rules.

 

For further Information:

 

Proxama PLC

Neil Garner, Chief Executive

Miles Quitmann, Chief Commercial Officer

Coen van Breda, Chief Financial Officer

020 7959 2298

 

Peel Hunt LLP

(Nominated Adviser and Broker)               

Richard Kauffer

Edward Fox

020 7418 8900

Cadogan PR

Alex Walters

0207 499 5002

07771713608

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOETPBLTMBTMBPI
UK 100

Latest directors dealings